Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5 alpha-reductase, and produces prostatic regression in male rats.

Neubauer BL, Best KL, Blohm TR, Gates C, Goode RL, Hirsch KS, Laughlin ME, Petrow V, Smalstig EB, Stamm NB, et al.

Prostate. 1993;23(3):181-99.

PMID:
8234065
2.

Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat.

Neubauer BL, Best KL, Clemens JA, Gates CA, Goode RL, Jones CD, Laughlin ME, Shaar CJ, Toomey RE, Hoover DM.

Prostate. 1993;23(3):245-62.

PMID:
8234067
4.
5.

Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds.

Nnane IP, Kato K, Liu Y, Long BJ, Lu Q, Wang X, Ling YZ, Brodie A.

Endocrinology. 1999 Jun;140(6):2891-7.

PMID:
10342882
7.

4-pregnene-3-one-20 beta-carboxaldehyde: a potent inhibitor of 17 alpha-hydroxylase/C17,20-lyase and of 5 alpha-reductase.

Li J, Li Y, Son C, Banks P, Brodie A.

J Steroid Biochem Mol Biol. 1992 May;42(3-4):313-20.

PMID:
1606043
8.

Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.

Klus GT, Nakamura J, Li JS, Ling YZ, Son C, Kemppainen JA, Wilson EM, Brodie AM.

Cancer Res. 1996 Nov 1;56(21):4956-64.

9.

Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.

Wright AS, Douglas RC, Thomas LN, Lazier CB, Rittmaster RS.

Endocrinology. 1999 Oct;140(10):4509-15.

PMID:
10499505
10.

Androgens are not major down-regulators of androgen receptor levels during growth of the immature rat penis .

Shen R, Lin MC, Sadeghi F, Swerdloff RS, Rajfer J, Gonzalez-Cadavid NF.

J Steroid Biochem Mol Biol. 1996 Mar;57(5-6):301-13. Erratum in: J Steroid Biochem Mol Biol 1996 Apr;58(1):137.

PMID:
8639466
11.

Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat.

di Salle E, Giudici D, Biagini L, Cominato C, Briatico G, Panzeri A.

J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):381-5.

PMID:
7626485
12.

Inhibition of androgen synthesis by 22-hydroximino-23,24-bisnor-4-cholen-3-one.

Li J, Li Y, Son C, Brodie AM.

Prostate. 1995 Mar;26(3):140-50.

PMID:
7534917
14.

FR146687, a novel steroid 5 alpha-reductase inhibitor: in vitro and in vivo effects on prostates.

Nakayama O, Hirosumi J, Chida N, Takahashi S, Sawada K, Kojo H, Notsu Y.

Prostate. 1997 Jun 1;31(4):241-9.

PMID:
9180934
15.

Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.

Prahalada S, Rhodes L, Grossman SJ, Heggan D, Keenan KP, Cukierski MA, Hoe CM, Berman C, van Zwieten MJ.

Prostate. 1998 May 15;35(3):157-64.

PMID:
9582084
16.

Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.

Lamb JC, English H, Levandoski PL, Rhodes GR, Johnson RK, Isaacs JT.

Endocrinology. 1992 Feb;130(2):685-94.

PMID:
1733716
19.

Effects of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo.

Nnane IP, Njar VC, Liu Y, Lu Q, Brodie AM.

J Steroid Biochem Mol Biol. 1999 Dec 15;71(3-4):145-52.

PMID:
10659703
20.

[The effects of antiprostatic agents on the accessory sex organs of rats treated with adrenal androgens].

Imai K, Takahashi O, Watanabe K, Nakazawa Y, Nakata S, Yamanaka H.

Hinyokika Kiyo. 1991 Dec;37(12):1669-76. Japanese.

Supplemental Content

Support Center